NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $421,091 | -23.9% | 34,235 | -0.6% | 0.00% | 0.0% |
| Q2 2023 | $553,515 | +91088.6% | 34,444 | -1.4% | 0.00% | -33.3% |
| Q1 2023 | $607 | +279.4% | 34,943 | +0.5% | 0.00% | +200.0% |
| Q4 2022 | $160 | -99.9% | 34,781 | +1.1% | 0.00% | 0.0% |
| Q3 2022 | $145,000 | +1015.4% | 34,395 | +1920.9% | 0.00% | – |
| Q2 2022 | $13,000 | +160.0% | 1,702 | +250.9% | 0.00% | – |
| Q1 2022 | $5,000 | -86.1% | 485 | -55.2% | 0.00% | – |
| Q4 2021 | $36,000 | +16.1% | 1,082 | +67.5% | 0.00% | – |
| Q3 2021 | $31,000 | +3.3% | 646 | -5.7% | 0.00% | – |
| Q2 2021 | $30,000 | +25.0% | 685 | +35.1% | 0.00% | – |
| Q1 2021 | $24,000 | +4.3% | 507 | +17.4% | 0.00% | – |
| Q4 2020 | $23,000 | +2200.0% | 432 | +953.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 41 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |